Stable incidence and survival of arteriovenous fistulas over 39 years: A long-term national cohort study

医学 期限(时间) 入射(几何) 外科 队列 内科学 人口学 动静脉瘘 数学 几何学 量子力学 物理 社会学
作者
Kristine Lindhard,Ditte Hansen,Brian Pedersen,Marianne Rix,Henrik Post Hansen,Boye L. Jensen,James Heaf
出处
期刊:Journal of Vascular Access [SAGE Publishing]
卷期号:24 (4): 620-629 被引量:2
标识
DOI:10.1177/11297298211046102
摘要

INTRODUCTION: The age and number of comorbidities in the hemodialysis population has increased over time. This may influence the construction and survival of the arteriovenous fistula (AVF). The present study explored the incidence and survival of AVFs over a period of 39 years. METHODS: A retrospective cohort study was conducted based on Danish registries. Incident hemodialysis patients between 1977 and 2015 were included. The incidence of AVF and factors associated with the construction of an AVF were described. Risk factors for AVF survival and repair were explored by Kaplan Meier and Cox proportional hazard analysis. RESULTS: The total number of arteriovenous accesses (AVF and arteriovenous grafts) were 10,187 and there were 4201 central venous catheters (CVC). No significant difference in the proportion of AVFs during the 39 years was seen. Age and renal diagnosis did not influence the proportion of AVFs. Patients with CVCs were found to have a significantly higher prevalence of comorbidities ( p < 0.01). AVF survival remained stable during the 39 years. The first constructed AVF had the best survival, 35% still functioning after 15 years. Factors such as brachiocephalic AVF, female sex, and diabetic nephropathy increased the risk of AVF failure (Odds Ratio (OR): 2.46, 95% Confidence Interval (CI) (2.29-2.65), 1.17 (1.10-1.25), and 1.21 (1.12-1.3)), respectively. CONCLUSION: Despite an older dialysis population, the proportion and survival of the AVF in the Danish dialysis population has not changed, probably because of increased awareness of AVF as the first choice of vascular access and improved surveillance, surgery, and repair.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shrimp5215完成签到,获得积分10
刚刚
琴power完成签到,获得积分10
2秒前
2秒前
2秒前
4秒前
无敌钢琴大王666完成签到,获得积分10
4秒前
顺心的书包完成签到,获得积分10
4秒前
ju00完成签到,获得积分10
4秒前
旷盐发布了新的文献求助10
5秒前
ping完成签到,获得积分10
5秒前
科研通AI6.1应助Zhengyiwu采纳,获得50
5秒前
江苏大猩猩完成签到,获得积分10
5秒前
一头小眠羊完成签到,获得积分10
5秒前
和谐的醉山完成签到,获得积分0
6秒前
热情代真完成签到,获得积分10
6秒前
IFYK完成签到,获得积分10
7秒前
晓听竹雨完成签到,获得积分10
7秒前
加载中发布了新的文献求助10
7秒前
7秒前
Zenobia完成签到,获得积分10
8秒前
huihui完成签到,获得积分10
8秒前
yaoyh_gc完成签到,获得积分10
8秒前
小熊完成签到,获得积分10
8秒前
zpf完成签到,获得积分10
8秒前
沉静灵枫完成签到,获得积分10
8秒前
菲菲完成签到 ,获得积分10
9秒前
luckygirl完成签到,获得积分10
9秒前
wang完成签到,获得积分10
9秒前
闫栋完成签到 ,获得积分10
10秒前
小艾同学完成签到,获得积分10
10秒前
颜琰发布了新的文献求助10
10秒前
hkh发布了新的文献求助10
11秒前
danli完成签到 ,获得积分10
11秒前
仙女完成签到 ,获得积分10
13秒前
hetao286发布了新的文献求助10
13秒前
ken完成签到,获得积分10
13秒前
激情的逍遥完成签到,获得积分20
13秒前
励志发SCI完成签到 ,获得积分10
14秒前
摩卡可可碎片星冰乐完成签到,获得积分10
14秒前
ggun完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6523306
求助须知:如何正确求助?哪些是违规求助? 8316285
关于积分的说明 17794527
捐赠科研通 5625271
什么是DOI,文献DOI怎么找? 2928214
邀请新用户注册赠送积分活动 1904918
关于科研通互助平台的介绍 1765054